circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer

被引：0
|
作者：
Hailin Tang
Xiaojia Huang
Jin Wang
Lu Yang
Yanan Kong
Guanfeng Gao
Lijuan Zhang
Zhe-Sheng Chen
Xiaoming Xie
机构：
[1] Sun Yat-sen University Cancer Center,Department of Breast Oncology
[2] State Key Laboratory of Oncology in South China,Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences
[3] Collaborative Innovation Center of Cancer Medicine,undefined
[4] St. John’s University,undefined
[5] Queens,undefined
来源：
Molecular Cancer | / 18卷
关键词：
Circular RNAs; miR-375; KIF4A; Competitive endogenous RNAs; Triple negative breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
    F Zagouri
    Z Bago-Horvath
    F Rössler
    A Brandstetter
    R Bartsch
    C A Papadimitriou
    C Dimitrakakis
    A Tsigginou
    I Papaspyrou
    A Giannos
    M-A Dimopoulos
    M Filipits
    British Journal of Cancer, 2013, 108 : 1100 - 1105
  • [42] Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
    Chee Leong Cheng
    Aye Aye Thike
    Sie Yong Jane Tan
    Pei Jou Chua
    Boon Huat Bay
    Puay Hoon Tan
    Breast Cancer Research and Treatment, 2015, 151 : 99 - 111
  • [43] SOCS1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer
    Qian, Qian
    Lv, Yuetao
    Li, Peng
    IUBMB LIFE, 2018, 70 (04) : 320 - 327
  • [44] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Speers, Corey
    Zhao, Shuang G.
    Chandler, Ben
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Ritter, Cassandra
    Alluri, Prasanna G.
    Kothari, Vishal
    Hayes, Daniel F.
    Lawrence, Theodore S.
    Spratt, Daniel E.
    Wahl, Daniel R.
    Pierce, Lori J.
    Feng, Felix Y.
    NPJ BREAST CANCER, 2017, 3 : 1 - 10
  • [45] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Corey Speers
    Shuang G. Zhao
    Ben Chandler
    Meilan Liu
    Kari Wilder-Romans
    Eric Olsen
    Shyam Nyati
    Cassandra Ritter
    Prasanna G. Alluri
    Vishal Kothari
    Daniel F. Hayes
    Theodore S. Lawrence
    Daniel E. Spratt
    Daniel R. Wahl
    Lori J. Pierce
    Felix Y. Feng
    npj Breast Cancer, 3
  • [46] Dipyridamole prevents triple-negative breast-cancer progression
    Spano, Daniela
    Marshall, Jean-Claude
    Marino, Natascia
    De Martino, Daniela
    Romano, Alessia
    Scoppettuolo, Maria Nunzia
    Bello, Anna Maria
    Di Dato, Valeria
    Navas, Luigi
    De Vita, Gennaro
    Medaglia, Chiara
    Steeg, Patricia S.
    Zollo, Massimo
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (01) : 47 - 68
  • [47] Dipyridamole prevents triple-negative breast-cancer progression
    Daniela Spano
    Jean-Claude Marshall
    Natascia Marino
    Daniela De Martino
    Alessia Romano
    Maria Nunzia Scoppettuolo
    Anna Maria Bello
    Valeria Di Dato
    Luigi Navas
    Gennaro De Vita
    Chiara Medaglia
    Patricia S. Steeg
    Massimo Zollo
    Clinical & Experimental Metastasis, 2013, 30 : 47 - 68
  • [48] Novel prognostic markers for patients with triple-negative breast cancer
    Zhou, Ling
    Li, Ke
    Luo, Yanli
    Tian, Ling
    Wang, Min
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (10) : 2180 - 2187
  • [49] Exploring specific prognostic biomarkers in triple-negative breast cancer
    Bao, Chang
    Lu, Yunkun
    Chen, Jishun
    Chen, Danni
    Lou, Weiyang
    Ding, Bisha
    Xu, Liang
    Fan, Weimin
    CELL DEATH & DISEASE, 2019, 10 (11)
  • [50] Prognostic impact of histological subtyping in triple-negative breast cancer
    Grosse, Claudia
    Noack, Petar
    Grosse, Alexandra
    Preuss, Caroline Ines
    Schwarz, Heike Kathleen
    Gitter, Thomas
    Schrenk, Peter
    Frauchiger-Heuer, Heike
    Papassotiropoulos, Barbel
    Tausch, Christoph
    Maccio, Umberto
    Moch, Holger
    Langer, Rupert
    Varga, Zsuzsanna
    HUMAN PATHOLOGY, 2024, 152
12345